Indefinite Delivery Contract 36C25023D0027

Award Date 2/1/23
Last Date to Order 1/31/28
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, with a potential value of $420,000. The contract establishes Jubilant Radiopharma as the supplier of nuclear medicine radiopharmaceuticals to support VA healthcare programs in the Norcross, Georgia area over a five-year period of performance from December...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single award indefinite delivery contract to Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, with a potential value of $866,632.41 to provide radio pharmaceuticals. Under this contract, two firm fixed price delivery orders have been awarded to date for a total of $441,612.06 to supply radiopharmaceutical products through January 2023...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded Jubilant Draximage Inc., doing business as Jubilant Radiopharma, Division Radiopharmaceutique, an Indefinite Delivery Contract (IDC) valued up to $3.5 million for the provision of radioactive isotopes and related radiopharmaceutical products and services. This single-award IDC with the VA VISN 10 network has a period of performance through September 30, 2026. Under this IDC, Jubilant Radiopharma, a...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a single-award, indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, for radiopharmaceuticals. The contract has a potential value of $638,068.78 and period of performance through April 30, 2025. Associated delivery orders include a $212,636.63 firm fixed-price order for radiopharmaceuticals with performance in Orlovista,...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 (VA-VHA) awarded a blanket purchase agreement to Jubilant Draximage Radiopharmacies, Inc. doing business as Jubilant Radiopharma for the provision of radiopharmaceutical supplies. Under the single award agreement, which has a potential value of $1,379,724.67 and expires on March 31, 2028, the contractor may receive delivery orders for radiopharmaceuticals through April 30, 2024. The first...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a single-award indefinite delivery requirements contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, to provide radiopharmaceuticals in support of patient care services. Three firm fixed price delivery orders were issued against the contract for a total value of $1.58M over a two year base period ending in April 2022. Delivery orders were...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded an indefinite delivery contract to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, to provide radiopharmaceutical products and services in support of VA medical facilities in Northern California. The single award contract has a potential value of $1,000,000 over five years from 2020 through 2025. Under the contract, Jubilant Radiopharma has received...
The U.S. Department of Veterans Affairs (VA) awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an Indefinite Delivery Contract (IDC) valued at up to $39.8 million to provide radiopharmaceuticals to VA medical facilities. Jubilant Radiopharma, a for-profit organization and self-certified small disadvantaged business, will supply diagnostic imaging agents, therapeutic radiopharmaceuticals, and nuclear medicine supplies, including products such as Ga-68...
The Department of Veterans Affairs (VA) has awarded an Indefinite Delivery Contract (IDC) to Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a for-profit small disadvantaged business. The $2.29 million single-award IDC, with a period of performance through January 2030, is for the supply of radiopharmaceuticals, including specialized medical isotopes, diagnostic imaging agents, and therapeutic radioisotopes, to support nuclear medicine procedures, PET scans,...
This federal contract IDV award is held by Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, a self-certified small disadvantaged business. The contract, valued up to $4,364,141.94, was awarded by the Department of Veterans Affairs (VA) to provide nuclear medicine imaging radiotherapeutic isotopes. Jubilant Radiopharma has been issued a $843,077.64 firm-fixed-price delivery order against this IDV to supply radioactive isotope doses to the VA's Veterans...
  • 36C25023D0027
    Indefinite Delivery Contract
  • 3
    Federal Contract Awards

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Jubilant Draximage Radiopharmacies, Inc., doing business as Jubilant Radiopharma, an indefinite-delivery contract with a potential value of $1,000,000 to provide radioactive isotopes to the Saginaw VA Medical Center over a five-year ordering period concluding on January 31, 2028. Two firm-fixed price delivery orders totaling $163,653 were also awarded under this contract, with periods of performance from February 1, 2023 to January 31, 2024 and February 1, 2024 to January 31, 2025 respectively. Place of performance will be Jubilant Radiopharma's facility in Norcross, Georgia.

This contract and associated delivery orders aim to support healthcare operations at VA facilities through the procurement of radioactive isotopes. No set-aside provisions were applied. The original pre-solicitation notice indicated the VA intended to award a lowest-price technically acceptable contract for these medical supplies following FAR Part 13.5 procedures. Radioactive isotopes are routinely used in nuclear medicine procedures to diagnose and treat conditions in veterans receiving care from the VA healthcare system.

Generated 1/4/24, 11:59 PM